Nuclear factor-κB inhibition provides additional protection against ischaemia/reperfusion injury in delayed sevoflurane preconditioning

Mojca Remskar Konia, Saul Schaefer, Hong Liu

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Background and objective Sevoflurane anaesthetic preconditioning (SPC) has been shown to limit nuclear factor-κB (NF-κB) activation and the production of inflammatory cytokines during myocardial ischaemia/ reperfusion (I/R). Similarly, pharmacological inhibition of NF-κB using parthenolide is effective in limiting I/R injury. We, therefore, postulated that the protective effect of delayed SPC would be enhanced by pharmacological NF- κB inhibition during I/R. Methods Hearts from 2-month-old male Fisher 344 rats were exposed to 25 min global ischaemia followed by 60 min reperfusion. Rats were divided into four groups prior to I/R: control group; parthenolide group, treated with the IκB kinase inhibitor parthenolide intraperitoneally 10 min prior to heart isolation; SPC group, treated for 60 min with sevoflurane 48 h prior to heart isolation; and SPC + parthenolide group, treated with SPC for 1 h followed by parthenolide 48 h later. Infarct area, left ventricular function and Ca2+,- were measured after I/R. Results Delayed SPC + parthenolide resulted in greater protection than either intervention alone, resulting in a significant reduction in infarct area and left ventricular developed pressure (mmHg; 84 ± 19 compared with 15 ± 14 in control hearts; P = 0.007). Left ventricular end- diastolic pressure also remained close to baseline values (9 ± 2 mmHg, P = 0.02) during I/R, and the increase in Ca2+,- seen with I/R was significantly blunted (P = 0.005). Conclusion SPC followed by parthenolide provides a significant protection from I/R injury in this model. As each intervention alone limits NF-κB activation with I/R, these data are consistent with additive effects of these dual modalities in limiting I/R injury due to NF-κB activation.

Original languageEnglish (US)
Pages (from-to)496-503
Number of pages8
JournalEuropean Journal of Anaesthesiology
Volume26
Issue number6
DOIs
StatePublished - Jun 2009

Fingerprint

Reperfusion Injury
Anesthetics
Reperfusion
Ischemia
Pharmacology
Myocardial Reperfusion
sevoflurane
Ventricular Pressure
parthenolide
Left Ventricular Function
Myocardial Ischemia
Phosphotransferases
Cytokines
Blood Pressure
Control Groups

Keywords

  • Delayed preconditioning
  • Myocardium
  • Nuclear factor-κB
  • Rat
  • Sevoflurane

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

@article{5347fd093a3a4637b7d4021fb3bce012,
title = "Nuclear factor-κB inhibition provides additional protection against ischaemia/reperfusion injury in delayed sevoflurane preconditioning",
abstract = "Background and objective Sevoflurane anaesthetic preconditioning (SPC) has been shown to limit nuclear factor-κB (NF-κB) activation and the production of inflammatory cytokines during myocardial ischaemia/ reperfusion (I/R). Similarly, pharmacological inhibition of NF-κB using parthenolide is effective in limiting I/R injury. We, therefore, postulated that the protective effect of delayed SPC would be enhanced by pharmacological NF- κB inhibition during I/R. Methods Hearts from 2-month-old male Fisher 344 rats were exposed to 25 min global ischaemia followed by 60 min reperfusion. Rats were divided into four groups prior to I/R: control group; parthenolide group, treated with the IκB kinase inhibitor parthenolide intraperitoneally 10 min prior to heart isolation; SPC group, treated for 60 min with sevoflurane 48 h prior to heart isolation; and SPC + parthenolide group, treated with SPC for 1 h followed by parthenolide 48 h later. Infarct area, left ventricular function and Ca2+,- were measured after I/R. Results Delayed SPC + parthenolide resulted in greater protection than either intervention alone, resulting in a significant reduction in infarct area and left ventricular developed pressure (mmHg; 84 ± 19 compared with 15 ± 14 in control hearts; P = 0.007). Left ventricular end- diastolic pressure also remained close to baseline values (9 ± 2 mmHg, P = 0.02) during I/R, and the increase in Ca2+,- seen with I/R was significantly blunted (P = 0.005). Conclusion SPC followed by parthenolide provides a significant protection from I/R injury in this model. As each intervention alone limits NF-κB activation with I/R, these data are consistent with additive effects of these dual modalities in limiting I/R injury due to NF-κB activation.",
keywords = "Delayed preconditioning, Myocardium, Nuclear factor-κB, Rat, Sevoflurane",
author = "Konia, {Mojca Remskar} and Saul Schaefer and Hong Liu",
year = "2009",
month = "6",
doi = "10.1097/EJA.0b013e328324ed2e",
language = "English (US)",
volume = "26",
pages = "496--503",
journal = "European Journal of Anaesthesiology",
issn = "0265-0215",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Nuclear factor-κB inhibition provides additional protection against ischaemia/reperfusion injury in delayed sevoflurane preconditioning

AU - Konia, Mojca Remskar

AU - Schaefer, Saul

AU - Liu, Hong

PY - 2009/6

Y1 - 2009/6

N2 - Background and objective Sevoflurane anaesthetic preconditioning (SPC) has been shown to limit nuclear factor-κB (NF-κB) activation and the production of inflammatory cytokines during myocardial ischaemia/ reperfusion (I/R). Similarly, pharmacological inhibition of NF-κB using parthenolide is effective in limiting I/R injury. We, therefore, postulated that the protective effect of delayed SPC would be enhanced by pharmacological NF- κB inhibition during I/R. Methods Hearts from 2-month-old male Fisher 344 rats were exposed to 25 min global ischaemia followed by 60 min reperfusion. Rats were divided into four groups prior to I/R: control group; parthenolide group, treated with the IκB kinase inhibitor parthenolide intraperitoneally 10 min prior to heart isolation; SPC group, treated for 60 min with sevoflurane 48 h prior to heart isolation; and SPC + parthenolide group, treated with SPC for 1 h followed by parthenolide 48 h later. Infarct area, left ventricular function and Ca2+,- were measured after I/R. Results Delayed SPC + parthenolide resulted in greater protection than either intervention alone, resulting in a significant reduction in infarct area and left ventricular developed pressure (mmHg; 84 ± 19 compared with 15 ± 14 in control hearts; P = 0.007). Left ventricular end- diastolic pressure also remained close to baseline values (9 ± 2 mmHg, P = 0.02) during I/R, and the increase in Ca2+,- seen with I/R was significantly blunted (P = 0.005). Conclusion SPC followed by parthenolide provides a significant protection from I/R injury in this model. As each intervention alone limits NF-κB activation with I/R, these data are consistent with additive effects of these dual modalities in limiting I/R injury due to NF-κB activation.

AB - Background and objective Sevoflurane anaesthetic preconditioning (SPC) has been shown to limit nuclear factor-κB (NF-κB) activation and the production of inflammatory cytokines during myocardial ischaemia/ reperfusion (I/R). Similarly, pharmacological inhibition of NF-κB using parthenolide is effective in limiting I/R injury. We, therefore, postulated that the protective effect of delayed SPC would be enhanced by pharmacological NF- κB inhibition during I/R. Methods Hearts from 2-month-old male Fisher 344 rats were exposed to 25 min global ischaemia followed by 60 min reperfusion. Rats were divided into four groups prior to I/R: control group; parthenolide group, treated with the IκB kinase inhibitor parthenolide intraperitoneally 10 min prior to heart isolation; SPC group, treated for 60 min with sevoflurane 48 h prior to heart isolation; and SPC + parthenolide group, treated with SPC for 1 h followed by parthenolide 48 h later. Infarct area, left ventricular function and Ca2+,- were measured after I/R. Results Delayed SPC + parthenolide resulted in greater protection than either intervention alone, resulting in a significant reduction in infarct area and left ventricular developed pressure (mmHg; 84 ± 19 compared with 15 ± 14 in control hearts; P = 0.007). Left ventricular end- diastolic pressure also remained close to baseline values (9 ± 2 mmHg, P = 0.02) during I/R, and the increase in Ca2+,- seen with I/R was significantly blunted (P = 0.005). Conclusion SPC followed by parthenolide provides a significant protection from I/R injury in this model. As each intervention alone limits NF-κB activation with I/R, these data are consistent with additive effects of these dual modalities in limiting I/R injury due to NF-κB activation.

KW - Delayed preconditioning

KW - Myocardium

KW - Nuclear factor-κB

KW - Rat

KW - Sevoflurane

UR - http://www.scopus.com/inward/record.url?scp=68849121799&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68849121799&partnerID=8YFLogxK

U2 - 10.1097/EJA.0b013e328324ed2e

DO - 10.1097/EJA.0b013e328324ed2e

M3 - Article

C2 - 19445059

AN - SCOPUS:68849121799

VL - 26

SP - 496

EP - 503

JO - European Journal of Anaesthesiology

JF - European Journal of Anaesthesiology

SN - 0265-0215

IS - 6

ER -